These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19299711)

  • 1. Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets.
    Reynolds AD; Stone DK; Mosley RL; Gendelman HE
    J Immunol; 2009 Apr; 182(7):4137-49. PubMed ID: 19299711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells.
    Reynolds AD; Stone DK; Mosley RL; Gendelman HE
    J Proteome Res; 2009 Jul; 8(7):3497-511. PubMed ID: 19432400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease.
    Reynolds AD; Glanzer JG; Kadiu I; Ricardo-Dukelow M; Chaudhuri A; Ciborowski P; Cerny R; Gelman B; Thomas MP; Mosley RL; Gendelman HE
    J Neurochem; 2008 Mar; 104(6):1504-25. PubMed ID: 18036154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrated alpha-synuclein and microglial neuroregulatory activities.
    Reynolds AD; Kadiu I; Garg SK; Glanzer JG; Nordgren T; Ciborowski P; Banerjee R; Gendelman HE
    J Neuroimmune Pharmacol; 2008 Jun; 3(2):59-74. PubMed ID: 18202920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease.
    Theodore S; Cao S; McLean PJ; Standaert DG
    J Neuropathol Exp Neurol; 2008 Dec; 67(12):1149-58. PubMed ID: 19018246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.
    Benner EJ; Banerjee R; Reynolds AD; Sherman S; Pisarev VM; Tsiperson V; Nemachek C; Ciborowski P; Przedborski S; Mosley RL; Gendelman HE
    PLoS One; 2008 Jan; 3(1):e1376. PubMed ID: 18167537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.
    Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF
    Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.
    Zhang QS; Heng Y; Yuan YH; Chen NH
    Toxicol Lett; 2017 Jan; 265():30-37. PubMed ID: 27865851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.
    Reynolds AD; Stone DK; Hutter JA; Benner EJ; Mosley RL; Gendelman HE
    J Immunol; 2010 Mar; 184(5):2261-71. PubMed ID: 20118279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration.
    Harms AS; Cao S; Rowse AL; Thome AD; Li X; Mangieri LR; Cron RQ; Shacka JJ; Raman C; Standaert DG
    J Neurosci; 2013 Jun; 33(23):9592-600. PubMed ID: 23739956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology.
    Christiansen JR; Olesen MN; Otzen DE; Romero-Ramos M; Sanchez-Guajardo V
    J Neuroinflammation; 2016 Apr; 13(1):74. PubMed ID: 27055651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Gallups NJ; Standaert DG; Harms AS
    Brain; 2021 Aug; 144(7):2047-2059. PubMed ID: 33704423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial innate immunity generated by non-aggregated alpha-synuclein in mouse: differences between wild-type and Parkinson's disease-linked mutants.
    Roodveldt C; Labrador-Garrido A; Gonzalez-Rey E; Fernandez-Montesinos R; Caro M; Lachaud CC; Waudby CA; Delgado M; Dobson CM; Pozo D
    PLoS One; 2010 Oct; 5(10):e13481. PubMed ID: 21048992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation and regulation of CD4
    Sun X; Gu R; Bai J
    Cell Mol Life Sci; 2024 Aug; 81(1):352. PubMed ID: 39153043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis.
    Choi YR; Kang SJ; Kim JM; Lee SJ; Jou I; Joe EH; Park SM
    Neurobiol Dis; 2015 Nov; 83():90-9. PubMed ID: 26342897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's disease.
    Thomas MP; Chartrand K; Reynolds A; Vitvitsky V; Banerjee R; Gendelman HE
    J Neurochem; 2007 Jan; 100(2):503-19. PubMed ID: 17241161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease.
    Reynolds AD; Banerjee R; Liu J; Gendelman HE; Mosley RL
    J Leukoc Biol; 2007 Nov; 82(5):1083-94. PubMed ID: 17675560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein.
    Béraud D; Hathaway HA; Trecki J; Chasovskikh S; Johnson DA; Johnson JA; Federoff HJ; Shimoji M; Mhyre TR; Maguire-Zeiss KA
    J Neuroimmune Pharmacol; 2013 Mar; 8(1):94-117. PubMed ID: 23054368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.